Navigation Links
China Sky One Medical, Inc. Interviewed in The China Perspective
Date:12/5/2008

HARBIN, China, Dec. 5 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that Mr. Yan-Qing Liu, Chairman, CEO and President of China Sky One Medical took part in an insightful interview in today's issue of The China Perspective.

As a well-known pharmaceutical company in China, China Sky One was honored to receive an interview from The China Perspective, a leading source of China business news, research and analysis that provides insight into the trends, companies and industries that are shaping the Chinese economy. During the interview, Mr. Yan-Qing Liu spoke about the Company's recent acquisitions, its R&D capability and the impact of global financial crisis on pharmaceutical producers. For more information, please visit The China Perspective's website ( http://www.thechinaperspective.com ).

"This is an exciting time in the evolution of the pharmaceutical industry in China, and China Sky One is well positioned to offer insight as a leading drug manufacturer and distributor in China," commented Mr. Yan-Qing Liu, Chairman, CEO and President of China Sky One Medical. "We are thrilled to work with The China Perspective and to share our reflections about the global economic crisis and our expertise in the Chinese pharmaceutical market with the investment community."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiari
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...y endpoint has been met for patients with advanced... QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEt... "Company"), a global biopharmaceutical company fo...ounced positive efficacy data from a Phase 2 study...ZS-108 (formerly AN-152), in patients with advance...
(Date:11/24/2009)... 24 Shire plc (LSE: SHP,...eutical company, today,announced that it has submi...laglucerase alfa, the company,s enzyme replacement...1 Gaucher disease. This is the third marketing,app...itted, with previous,submissions in the United Sta...
(Date:11/24/2009)...., Nov. 24 Genomic Healt...y Scott, Genomic Health,s Executive Chairman, will...are Conference in New York City on Tuesday, Decemb...live and subsequently archived webcast of the pres...Genomic Health,s website at http://investor.genom...
(Date:11/24/2009)... Connects Customers with Partners Validated to Pro...k Products , Ottawa, ON (...ng provider of products for biological sample coll...nced its new global partner program. The program o...artner community and is designed to help partners ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...JAVIK, Iceland, and ALAMEDA, California, April 23,...ration (NASDAQ: CRA ) today announced the signing...ra non-exclusive worldwide licenses to deCODE,s,ge...scular and metabolic,diseases, including heart att...iabetes (T2D). These markers can be incorporated i...
...GCHUN, China and LOS ANGELES, April 23 /PRNewswire...nue Increased 28.6% to $14.1 Million, with Net, ..., - 2008 Revenues Increased 23.5% to $59.1 Mill...ed 340 Basis Points to 20.1%, - 2008 Net Income...of, $0.13, - 2008 Cash Flow from Operation...
...omarker predicts likelihood of recurrence and long...nts; Further strengthens Company,s breast cancer m..., Inc. , (Nasdaq: CLRT ), a premier anatomic pa...r pathologists, oncologists and the pharmaceutical...d an exclusive intellectual property license from ...
Other Biology Technology:deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 2deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 3deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 4deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 5deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 6deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 2China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 3China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 4China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 5China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 6China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 7China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 8China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 9China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 10China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results 11Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 2Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 3Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 4Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation 5
(Date:11/24/2009)...protein that may help gut bacteria bind to the gas...probiotic producers to identify strains that are l...ics need to interact with cells lining the gut to ...rfaces in the gut they are more likely to stick ar... Nathalie Juge from the Institute of Food Research...
(Date:11/24/2009)...ong held secrets of the earth,s history locked in ... very little information on the environments that ... of years. Now, a team of researchers from nine in... tune of $10 million dollars by the National Scien...ngs literally. These scientists will drill throug...
(Date:11/23/2009)...-associated strain of the deadly superbug MRSAan i... antibioticsposes a far greater health threat than...tals, according to a study in the December issue o...eat is easily picked up in fitness centers, school...verall burden of MRSA within hospitals, the report...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Custom Spine Announces New Board of Directors and CFO 52778 1Custom Spine Announces New Board of Directors and CFO 52778 2Olympus Managed Health Care Receives Third Party Administrative License in State of Florida 52776 1Northside Medical Center Nurses Reach Tentative Agreement with Forum Health 52774 1
...easing ventilation within aircraft cabins can redu...ggests a review published in this week,s issue of ...Centre, MA, USA) and colleagues reviewed data from...uring commercial air travel. They found that while...r the spread of pathogens carried by passengers or...
...h is more likely to happen - you being in a car wr...red that cars are greater killers win a free trip ... A&M University professor. Your chances of bei... lunch, says John McEachran, a professor of wildli... years. , Worldwide, about one million people a ye...
...ou thought the sleep-deprived months with your new...iller whale. , Reporting in the June 30 edition o...Affairs neuroscientists report a developmental pat... is unique from other mammals, with calves of both...month. , The mother also has minimal sleep during ...
Other Biology News:Aircraft Cabin Ventilation Influences The Transmission Of Diseases In-flight 2New HIV drug candidate developed in Sweden 2Unlike other mammals, newborn dolphins and orcas stay active 24/7 during first months of development 2
... wide range of next-generation features into a sma... for flexible laboratory solutions. It puts every ...lution, dispensing, and integrations into a singl... as it is efficient and economical. The Biomek NX ...
BD Falcon 96-well Flat-bottom ELISA Plates from BD Biosciences - Discovery Labware
Detergent-OUT Micro Kit from CHEMICON
Detergent-OUT (SDS) from CHEMICON
Biology Products: